ARTELO BIOSCIENCES, INC.

ARTL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $4.2M $4.2M $600.0K $1.7M $2.1M $746.0K $2.3M $4.4M
Accounts Receivable
Inventory
Total Current Assets $4.4M $10.4M $695.0K $1.8M $2.2M $1.4M $2.6M $5.0M
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill) $2.0M $2.0M $2.0M $2.0M $2.0M $2.0M $2.0M $2.0M
Total Assets $6.5M $12.5M $2.8M $4.3M $4.4M $3.5M $4.7M $7.1M
Liabilities
Accounts Payable
Total Current Liabilities $1.5M $5.8M $4.0M $4.9M $5.7M $2.8M $1.8M $697.0K
Long-Term Debt
Total Liabilities $1.5M $5.8M $4.1M $4.9M $5.8M $2.9M $1.8M $775.0K
Stockholders' Equity
Retained Earnings $-68.4M $-66.0M $-63.0M $-58.8M $-55.7M $-52.5M $-50.1M $-46.4M
Total Stockholders' Equity $5.0M $6.7M $-1.3M $-633.0K $-1.4M $652.0K $2.9M $6.4M
← Newer Page 1 of 6 Older →